» Articles » PMID: 34690522

Welfare Economics of Managing an Epidemic: an Exposition

Overview
Date 2021 Oct 25
PMID 34690522
Authors
Affiliations
Soon will be listed here.
Abstract

This paper reviews recent findings on the normative analysis of private and governmental countermeasures against infectious diseases, focusing on COVID-19. Based on a model that relates the economic activity to infectious disease epidemics, policies that maximize social welfare are considered. Lockdowns in many countries are measures that restrict economic activity over a wide area, and the economic damage they cause is extremely large. Existing studies on the net benefit of lockdown implemented in 2020 have reached mixed conclusions as to whether it is warranted or not. Although the estimates of costs and effects are relatively stable, the setting of the value of a statistical life for converting effects into benefits has a wide range and is also likely to overestimate benefits. Therefore, a careful procedure for setting is particularly crucial to obtain a reliable evaluation of countermeasures. Compared to uniform restriction of activities, taking measures to restrict activities by selecting targets may improve efficiency. Attributes that can be used to select targets include those that can be identified at little or no cost, such as age and industry, and those that can only be identified at a cost, such as close contact with infectious individuals and the presence of pathogens. In comparison to lockdown, these measures may reduce human suffering and economic suffering. No trade-off exists between uniform activity restrictions and selective activity restrictions.

References
1.
Munasinghe L, Asai Y, Nishiura H . Quantifying heterogeneous contact patterns in Japan: a social contact survey. Theor Biol Med Model. 2019; 16(1):6. PMC: 6425701. DOI: 10.1186/s12976-019-0102-8. View

2.
Diekmann O, Heesterbeek J, Metz J . On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations. J Math Biol. 1990; 28(4):365-82. DOI: 10.1007/BF00178324. View

3.
Miles D, Stedman M, Heald A . "Stay at Home, Protect the National Health Service, Save Lives": A cost benefit analysis of the lockdown in the United Kingdom. Int J Clin Pract. 2020; 75(3):e13674. PMC: 7435525. DOI: 10.1111/ijcp.13674. View

4.
Scherbina A . Assessing the Optimality of a COVID Lockdown in the United States. Econ Disaster Clim Chang. 2021; 5(2):177-201. PMC: 8105692. DOI: 10.1007/s41885-021-00083-6. View

5.
Ibuka Y, Ohkusa Y, Sugawara T, Chapman G, Yamin D, Atkins K . Social contacts, vaccination decisions and influenza in Japan. J Epidemiol Community Health. 2015; 70(2):162-7. PMC: 4752620. DOI: 10.1136/jech-2015-205777. View